Ryan Walsh, MD, PhD, is a board-certified neurologist at the Muhammad Ali Parkinson Center at Barrow Neurological Institute. In addition, he is fellowship-trained in movement disorders.
Dr. Walsh’s clinical expertise includes caring for patients with Parkinson’s disease and all other movement disorders. He is a member of the American Academy of Neurology, the International Parkinson and Movement Disorder Society, and the Alpha Omega Alpha National Medical Honor Society.
Dr. Walsh earned his medical degree and PhD from the NIH-funded Medical Scientist Training Program at the University of Cincinnati College of Medicine. He completed his neurology residency at the University of Chicago Medical Center, where he also pursued postdoctoral training in neuroimaging. He then completed a fellowship in movement disorders at the University of Alabama at Birmingham.
Dr. Walsh’s research interests include cognitive impairment and neuro-imaging in Parkinson’s disease. He was integral in conducting new neuro-imaging research during his tenure at the Cleveland Clinic Lou Ruvo Center for Brain Health, including serving as principal investigator of one of three research projects for a large National Institutes of Health (NIH) award. Dr. Walsh’s efforts have garnered several honors and awards, including being recognized by the American Academy of Neurology as one of 12 individuals nationally selected for their inaugural Emerging Leaders Program.
To request an appointment with Dr. Walsh, call (602) 406-6262.
Fax: (602) 406-6261
- Fellowship, University of Alabama at Birmingham, Movement Disorders, 2008-2010
- Residency, University of Chicago Medical Center, Neurology, 2005-2008
- Internship, University of Chicago Medical Center, Internal Medicine, 2004-2005
- MD, University of Cincinnati College of Medicine, 2004
- PhD, University of Cincinnati College of Medicine, 2004
- BS, Georgetown University, Biology, 1995
- Alpha Omega Alpha National Medical Honor Society
- American Academy of Neurology (AAN)
- International Parkinson and Movement Disorder Society (MDS)
- Huntington Study Group
- Parkinson Study Group
- Global Multiple System Atrophy Taskforce
- Selected to Inaugural American Academy of Neurology Emerging Leaders Forum, 2012-2013
- Graduate, UAB Clinical and Translational Science Training Program, 2010
- Scholarship Recipient, American Neurological Association’s Second Annual Summer Course for Clinical and Translational Researchers in Neurology and Neuroscience, 2009
- Resident Scholarship Recipient, Annual Meeting of the American Academy of Neurology, 2008
- Elected to Alpha Omega National Medical Honor Society, 2004
- Pre-Doctoral Fellowship, Scottish Rite Foundation for Schizophrenia Research, 1998-2002
- Cardell Foundation Graduate Award: Outstanding Research in Microscopy, 1999
- Cum Laude Graduate, Georgetown University, 1996
- Cummings JL, Banks SJ, Gary RK, Kinney JW, Lombardo JM, Walsh RR, Zhong K. Alzheimer’s disease drug development: translational neuroscience strategies. CNS Spectr. 2013;18(3):128-138.
- Walsh RR, Small SL, Chen EE, Solodkin A. Network activation during bimanual movements in humans. Neuroimage. 2008;43(3):540-553.
- Walsh R, Baldwin M, Sharma K, Rosengart AJ. Stepping movements induced by acute spinal cord injury. Neurology. 2008;70(21):2008-2009.
- Javed A, Balabanov R, Arnason BG, Kelly TJ, Sweiss NJ, Pytel P, Walsh R, Blair EA, Stemer A, Lazzaro M, Reder AT. Minor salivary gland inflammation in Devic’s disease and longitudinally extensive myelitis. Mult Scler. 2008;14(6):809-814.
- Zhang J, Moseley A, Jegga AG, Gupta A, Witte DP, Sartor M, Medvedovic M, Williams SS, Ley-Ebert C, Coolen LM, Egnaczyk G, Genter MB, Lehman M, Lingrel J, Maggio J, Parysek L, Walsh R, Xu M, Aronow BJ. Neural system-enriched gene expression: relationship to biological pathways and neurological diseases. Physiol Genomics. 2004;18(2):167-183.
- Zhang J, Walsh RR, Xu M. Probing the role of the dopamine D1 receptor in psychostimulant addiction. Ann N Y Acad Sci. 2000;914:13-21.